About Damien

Damien is the Practice Team Leader for the Maddocks Corporate & Private clients team in Victoria.

Damien advises a range of Australian corporates (listed and unlisted), Australian subsidiaries of multi-national companies and founder owned businesses on mergers, acquisitions and disposals and on their other commercial requirements. He has worked extensively across a number of industries including civil construction, industrials, pharmaceuticals and health.

Highly regarded by his clients, Damien looks beyond the specific matter at hand, to take care of the whole situation. His clients turn to him for advice that goes beyond his legal remit, to seek his counsel on strategic and commercial matters.

Damien is recommended by Legal 500 Asia Pacific (2023) for his work in Corporate M&A and by Doyle’s Guide for Corporate Law and M&A.

Experience

• Australian corporates (listed and unlisted)
  Advising companies on a diverse range of critical and commercially sensitive transactions, which are often transformational for organisations and career-defining for individuals. These include acquisitions, takeovers and financing, as well as business as usual matters.
• Australian subsidiaries of global companies
  Often working in collaboration with a network of international advisors, Damien ensures our clients’ positions are represented in the region and that they remain fully advised on any Australia-related developments and implications.
• Founder-owned businesses
  Advising founder and family owned businesses to help them to prepare for a liquidity event, including working with a network of other advisors to best position stakeholders for a clean exit at a premium valuation – or for the introduction of a constructive, strategic partner to support the future of the business.
• Pharmaceuticals
  Damien has a wholistic understanding of the pharmaceutical supply chain, having advised government bodies, industry representative bodies, originators and generics suppliers, wholesalers and other distributors, financiers and pharmacists. His understanding of the numerous regulatory overlays and profit drivers means that he is able to adopt an enhanced and strategic approach to the mergers and acquisitions he becomes involved in.